Table 5.

Strain values between two groups.

	Control	Chemotherapy	p value
GLS (%)	-21.86 ± 2.38	-20.36 ± 2.58	0.016*
GCS (%)	-27.73 ± 3.37	-24.94 ± 4.14	0.004*
GRS (%)	31.44 ± 12.98	26.89 ± 9.75	0.118
LS-ENDO(%)	-25.21 ± 2.72	-23.38 ± 3.11	0.014*
LS-MID(%)	-21.53 ± 2.36	-20.35 ± 2.58	0.029*
LS-EPI(%)	-18.83 ± 2.19	-17.35 ± 2.48	0.013*
LS gradient (%)	-6.38 ± 1.28	-6.03 ± 2.07	0.439
CS-ENDO(%)	-37.37 ± 3.79	-32.88 ± 5.23	0.000*
CS-MID(%)	-26.24 ± 2.98	-24.62 ± 4.13	0.073
CS-EPI(%)	-19.56 ± 4.45	-17.32 ± 4.13	0.066
CS gradient(%)	-17.80 ± 3.69	-15.55 ± 4.59	0.0*

CS-ENDO: subendocardial circumferential strain; CS-EPI: subepicardial circumferential strain; CS-MID: middle circumferential strain; GCS: global circumferential strain; GLS: global longitudinal strain; GRS: global radial strain; LS-ENDO: subendocardial longitudinal strain; LS-EPI: subepicardial longitudinal strain; LS-MID: middle longitudinal strain.

^*p < 0.05. p values were assessed by independent samples t test